Mesa Laboratories, Inc. MLAB
NASDAQ
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 3.65% | -5.63% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.65% | -5.63% | |||
| Cost of Revenue | 6.31% | -1.83% | |||
| Gross Profit | 2.22% | -7.57% | |||
| SG&A Expenses | -3.00% | -20.33% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.58% | -12.91% | |||
| Operating Income | 19.30% | 155.86% | |||
| Income Before Tax | 38.62% | 373.26% | |||
| Income Tax Expenses | 11.16% | -40.11% | |||
| Earnings from Continuing Operations | 53.39% | 168.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 53.39% | 168.42% | |||
| EBIT | 19.30% | 155.86% | |||
| EBITDA | 10.04% | 49.16% | |||
| EPS Basic | 53.73% | 167.06% | |||
| Normalized Basic EPS | 38.95% | 367.76% | |||
| EPS Diluted | 53.06% | 165.68% | |||
| Normalized Diluted EPS | 38.53% | 363.14% | |||
| Average Basic Shares Outstanding | -0.23% | 2.04% | |||
| Average Diluted Shares Outstanding | 0.05% | 3.84% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.34% | 2.46% | |||